OCLS Share Price

Open 4.82 Change Price %
High 4.95 1 Day 0.08 1.64
Low 4.81 1 Week 0.08 1.64
Close 4.95 1 Month 0.45 10.00
Volume 13830 1 Year 3.81 334.21
52 Week High 5.65
52 Week Low 0.00
OCLS Important Levels
Resistance 2 5.08
Resistance 1 5.03
Pivot 4.90
Support 1 4.87
Support 2 4.82
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
ETRM 0.07 40.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.66 1.08%
MU 20.66 1.08%
More..
NASDAQ USA Top Gainers Stocks
SSH 0.58 176.19%
SSH 0.58 176.19%
SSH 0.58 176.19%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
IRG 0.43 72.00%
MBLX 0.51 64.52%
COOL 5.17 63.61%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
SHIP 1.20 -45.45%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)

OCLS Technical Analysis 5
As on 5th Dec 2016 OCLS Share Price closed @ 4.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.59 & Strong Buy for SHORT-TERM with Stoploss of 4.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
OCLS Target for December
1st Target up-side 5.47
2nd Target up-side 5.94
3rd Target up-side 6.41
1st Target down-side 4.15
2nd Target down-side 3.68
3rd Target down-side 3.21
OCLS Other Details
Segment EQ
Market Capital 26042852.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.oculusis.com
OCLS Address
OCLS
1129 North Mcdowell Boulevard
Petaluma, CA 94954
United States
Phone: 707-283-0550
Fax: 707-283-0551
Interactive Technical Analysis Chart Oculus Innovative Sciences, Inc. ( OCLS NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oculus Innovative Sciences, Inc.
OCLS Business Profile
Oculus Innovative Sciences, Inc. is a global healthcare company that designs, produces, and markets prescription and non-prescription products in over 20 countries.The Company�s focus is on the commercialization of its technology platform called Microcyn Technology. Outside the United States, its Microcyn Technology products have a CE Mark device approval in Europe for debriding, irrigating and moistening acute and chronic wounds in comprehensive wound treatment by reducing microbial load and creating a moist environment. In Mexico, it is approved as a drug for antiseptic. In India, its technology has a drug license for cleaning and debriding in wound management. In China, it has obtained a medical device approval by the State Food and Drug Administration for reducing the propagation of microbes in wounds and creating a moist environment for wound healing.